Blood culture molecular ID system for portland VAMC
Ended Awarded Last action
- Contract number
- 36C26021F0149
- Awardee
-
Luminex Corp UEI VLLHHV5E3AL1
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $233,734
Award facts
- Contract value 47% obligated
-
- $393,334.48 Current, with exercised options
- $499,734.48 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6630 Chemical Analysis Instruments
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Austin, TX 78727, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $26,600 | |
| Funding Only Action | -$21,726 | |
| Exercise an Option | $53,200 | |
| Supplemental Agreement for work within scope | -$33,869 | |
| Exercise an Option | $0 | |
| Exercise an Option | $53,200 | |
| Exercise an Option | $53,200 | |
| Funding Only Action | -$3,271 | |
| Exercise an Option | $53,200 | |
| Original award | $53,200 |
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 20, awarded a $499.7K delivery order to Luminex Corp on January 9, 2021, for a blood culture molecular identification system to support the Portland VA Medical Center. The contract, which utilizes Luminex's GSA Schedule vehicle for In Vitro Diagnostics, Reagents, and Test Kits (FSS-65-VII), carries a firm fixed price structure with no set-aside designation and is scheduled for completion by July 8, 2026. Luminex Corp, headquartered in Austin, Texas, is a manufacturer of advanced biological testing technologies specializing in multiplex diagnostic solutions and laboratory equipment, with a strong track record of federal contracting across the Department of Veterans Affairs, Department of Defense, Centers for Disease Control and Prevention, and other agencies.
This delivery order supports the VA's clinical laboratory diagnostic capabilities by providing molecular identification technology for blood culture testing, which is critical for rapid pathogen identification and appropriate antimicrobial therapy. The award reflects Luminex's established position as a competitive federal contractor for sophisticated diagnostic instrumentation and related testing services, building upon the company's existing $519.1K blanket purchase agreement with the Department of Veterans Affairs for polymerase chain reaction testing services. The procurement leverages the GSA Schedule to streamline acquisition of specialized diagnostic solutions necessary for modern healthcare delivery within the Veterans Health Administration.
Quick answers
Who was awarded contract 36C26021F0149?
36C26021F0149 was awarded to Luminex Corp by Veterans Integrated Service Network 20 (Veterans Health Administration) on January 9, 2021.
How much is contract 36C26021F0149 worth?
The government has obligated $233,734 on 36C26021F0149. Its current value, with exercised options, is $393,334. Its potential value, with all options, is $499,734.
Is contract 36C26021F0149 an order under another contract?
Yes. 36C26021F0149 is a delivery order under 36F79719D0244, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C26021F0149 competed?
The extent of competition for 36C26021F0149 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award